IMI project results in diabetes, TB, pain and more
Register now for our event on early career researchers
How do public-private partnerships like IMI projects help early career researchers (ECRs) get ahead professionally? Find out from ECRs from a number of IMI projects at our online event on 17 April.
Details and registration ❯
Understanding the genetic link between obesity and type 2 diabetes
IMI project SOPHIA is shedding new light on the mechanisms that can cause type 2 diabetes in obesity, as well as the factors that keep some people with obesity diabetes-free.
Read more ❯
Examining data in new ways highlights genetic differences in psoriatic skin
IMI project BIOMAP has uncovered previously unknown genetic factors associated with the onset of psoriasis, a disease that is characterised by red, scaly patches on the skin.
Read more ❯
How can low- and middle-income countries roll out molecular diagnostics for TB?
UNITE4TB explored how low- and middle-income countries can roll out the molecular diagnostic tests needed to determine the best course of treatment for people diagnosed with tuberculosis (TB).
Read more ❯
New electrode improves pain perception research
The IMI-PainCare project has developed a new electrode to investigate pain perception in a clinical recreation of chronic pain, a condition which affects 1 in 5 Europeans.
Read more ❯
European Lead Factory search reveals chemicals that could lead to a new COVID-19 treatment
The project looked for compounds that stop the virus's spike protein from binding with the ACE2 receptor which is found on human cells and is the virus's main route of attack.
Read more ❯
Catch up on the PharmaLedger spotlight event
Missed our webinar on healthcare and blockchain project PharmaLedger? You can watch the recording and download the presentations from the event web page.
Find out more ❯
IHI call 3 attracts 19 proposals
The call addresses diseases of unmet need, rare diseases, mental health, hospital efficiencies, and patient-generated evidence. Eligible proposals will be evaluated by independent experts.
Find out more ❯
Innovative Health Initiative